tiprankstipranks
Advertisement
Advertisement
Sellas Life Sciences to present preclinical SLS009 data at AACR conference
PremiumThe FlySellas Life Sciences to present preclinical SLS009 data at AACR conference
12d ago
SELLAS (SLS): Advancing AML Pipeline, Strengthened Balance Sheet, and Upcoming Catalysts Drive Higher Target and Buy Rating
Premium
Ratings
SELLAS (SLS): Advancing AML Pipeline, Strengthened Balance Sheet, and Upcoming Catalysts Drive Higher Target and Buy Rating
16d ago
Sellas announces enrollment of first patient in Phase 2 SLS009 trial
Premium
The Fly
Sellas announces enrollment of first patient in Phase 2 SLS009 trial
18d ago
Unusually active option classes on open February 23rd
PremiumThe FlyUnusually active option classes on open February 23rd
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Mixed options sentiment in Sellas Life Sciences with shares down 1.75%
Premium
The Fly
Mixed options sentiment in Sellas Life Sciences with shares down 1.75%
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
Unusually active option classes on open December 29th
Premium
The Fly
Unusually active option classes on open December 29th
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100